Dynepo Infrequent Dosing Study

NCT00450333 · clinicaltrials.gov ↗
PHASE3
Phase
TERMINATED
Status
407
Enrollment
INDUSTRY
Sponsor class

Stopped The termination of the study is not linked to a product recall or result of any safety signal. Rather it was sponsor's commercial decision to withdraw the MA

Conditions

Interventions

Sponsor

Shire